Abstract
It is critical to detect latent tuberculosis infection through screening and testing individuals at high risk of progression to active tuberculosis, including patients who are immunocompromised. NPs should be familiar with available testing for accurate diagnosis in order to expedite treatment.
Author supplied keywords
- CLIA
- ELISA
- ELISPOT
- IGRAs
- PPD skin test
- TB
- TST
- chemiluminescence immunoassay
- diagnostic testing
- enzyme-linked immunosorbent assay
- enzyme-linked immunosorbent spot
- immunocompromise
- immunosuppressive medications
- latent tuberculosis infection
- purified protein derivative test
- screening and testing
- tuberculin skin test
- tuberculosis
Cite
CITATION STYLE
APA
Sierra, C. J., & Downs, C. A. (2022). Screening and testing for latent tuberculosis infection among patients who are immunocompromised. Nurse Practitioner, 47(11), 32–39. https://doi.org/10.1097/01.NPR.0000884860.99026.ee
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free